您好，欢迎来到试剂信息网！ [登录] [免费注册]
试剂信息网
发布求购
位置：首页 > 产品库 > AZ 10606120 dihydrochloride
立即咨询
咨询类型：
     
*姓名：
*电话：
*单位：
Email：
*留言内容：
请详细说明您的需求。
*验证码：
 
AZ 10606120 dihydrochloride
本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
AZ 10606120 dihydrochloride图片
CAS NO:607378-18-7
包装与价格：
包装价格(元)
10mg电议
50mg电议

产品介绍
AZ 10606120 dihydrochloride 是一种选择性的、高亲和力的 P2X7 受体 (P2X7R) 拮抗剂，作用于人和大鼠，IC50 为 ~10 nM。
Cas No.607378-18-7
化学名(Z)-2-((3r,5r,7r)-adamantan-1-yl)-N-((E)-2-((2-((2-hydroxyethyl)amino)ethyl)imino)-1,2-dihydroquinolin-5-yl)acetimidic acid dihydrochloride
Canonical SMILESOCCNCC/N=C1C=CC2=C(N\1)C=CC=C2/N=C(O)/CC34C[C@@]5([H])C[C@](C3)([H])C[C@](C4)([H])C5.Cl.Cl
分子式C25H34N4O2.2HCl
分子量495.48
溶解度<12.39mg/ml in Water;<49.55mg/ml in DMSO
储存条件Desiccate at RT
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

KD: 1.4 nM and 1.9 nM for human and rat P2X7 receptors, respectivley

The P2X7 receptor has intriguing biophysical properties, activates a diverse range of cellular events and mediates a wide range of functional effects. The P2X7 receptor is an ATP-gated ion channel known for its cytotoxic activity. However, recent evidence suggests a role for P2X7 in cell proliferation. AZ 10606120 is a P2X7 receptor antagonist.

In vitro: Binding of [3H]-AZ 10606120 was higher in membranes prepared from cells expressing P2X7 receptors than from control cells and was inhibited by ATP suggesting labelled sites represented human P2X7 receptors. Binding was reversible, saturable and modulated by P2X7 receptor ligands. The positive cooperativity observed suggests that binding of AZ 10606120 to one subunit in the P2X7 receptor complex enhances subsequent binding to other P2X7 subunits in the same complex. The negative cooperative effects of ATP suggest that ATP and AZ 10606120 bind at separate, interacting, sites on the P2X7 receptor [1].

In vivo: Intratumor injection of AZ10606120 caused a strong inhibition of tumor growth in B16-inoculated C57Bl/6 mice and caused in parallel a large reduction in VEGF staining and vessel formation [2].

Clinical trial: Up to now, AZ 10606120 is still in the preclinical development stage.

Reference:
[1] AD Michel, LJ Chambers, WC Clay, JP Condreay, DS Walter and IP Chessell.  Direct labelling of the human P2X7 receptor and identification of positive and negative cooperativity of binding. British Journal of Pharmacology (2007) 151, 84–95
[2] Elena Adinolfi, Lizzia Raffaghello, Anna Lisa Giuliani, Luigi Cavazzini, Marina Capece, Paola Chiozzi, Giovanna Bianchi, Guido Kroemer, Vito Pistoia, and Francesco Di Virgilio.  Expression of P2X7 Receptor Increases In Vivo Tumor Growth. Cancer Res; 72(12); 2957–69.